Coordination of European funding for infectious diseases research

Basic Information


Infectious diseases (ID) also known as communicable diseases are one of the majorcauses of death worldwide. Every year in Europe, infectious diseases cause tens of thousands of deaths (from ECDC Microbes without borders: key facts on infectious diseases in Europe 2007 report). In order to address the challenges in ID and design adapted treatments, as well as diagnostic and preventive tools, the funding programmes involved in The INFECT-ERA aim to support all basic aspects of human infection biology caused by bacteria, fungi, viruses and protozoa. To that end, research addressing the cross-talk between host and pathogens, as well as the relationship between microbes environment and infection will be supported by Infect-ERA. In addition, this ERA-NET aims to (i) strengthen the development and improvement of innovative tools and methodologies to address infection biology as a whole and (ii) promote the integration of new tools to carry out research.

Main research priorities of the network

infectious diseases, infectiology, technology driven research, microbes environment and virulence, host-pathogen interaction, co-infection

Research fields covered by the network

  • Biotechnology
  • Health

Target Groups

  • Public Research Organisations (PROs)
  • Private and Semi-private Research and Technology Organisations (RTOs)
  • SME (Small and Medium Enterprises)

Is connected with

Joint Calls

Joint Call Title Type Launch Date Deadline
End Date
Infect-ERA 4th transnational joint call on human infectious diseases two-stages 18/01/2016 17/03/2016

Submitted: 124


Submitted: 34


Funded: 9

Infect-ERA 3rd transnational joint call on human infectious diseases two-stages 19/01/2015 18/03/2015

Submitted: 110


Submitted: 35


Funded: 9

Infect-ERA 2nd transnational joint call on human infectious diseases two-stages 26/02/2014 02/04/2014

Submitted: 118


Submitted: 34


Funded: 8

Infect-ERA 1st transnational joint call on human infectious diseases two-stages 26/02/2013 19/04/2013

Submitted: 96


Submitted: 36


Funded: 8